Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer

Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer

Background Corticosteroids (CS) are the mainstay of immune-related adverse effect (irAE) management, as well as for other indications in cancer treatment. Previous studies evaluating whether CS affect immune checkpoint inhibitor (CPI) efficacy compared patients receiving CS versus no CS. However, th...

Full description

Bibliographic Details
Main Authors: Richa Goel, Zoe Blake, Daniel H Johnson, Karine Tawagi, Victoria Simenson, Helen Yuan, Cameron Parent, Adi Bamnolker, Diana V Maslov, Madhav KC, Marc R Matrana
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/7/e002261.full

Internet

https://jitc.bmj.com/content/9/7/e002261.full

Similar Items